These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Stone J, Chan-Ling T, Pe'er J, Itin A, Gnessin H, Keshet E. Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):290-9. PubMed ID: 8603833 [Abstract] [Full Text] [Related]
7. Regulation of retinal vascular endothelial growth factor and receptors in rabbits exposed to hyperoxia. Ozaki NK, Beharry KD, Nishihara KC, Akmal Y, Ang JG, Sheikh R, Modanlou HD. Invest Ophthalmol Vis Sci; 2002 May; 43(5):1546-57. PubMed ID: 11980873 [Abstract] [Full Text] [Related]
8. The 67-kd laminin receptor is preferentially expressed by proliferating retinal vessels in a murine model of ischemic retinopathy. Stitt AW, McKenna D, Simpson DA, Gardiner TA, Harriott P, Archer DB, Nelson J. Am J Pathol; 1998 May; 152(5):1359-65. PubMed ID: 9588904 [Abstract] [Full Text] [Related]
10. Expression and activation of STAT3 in ischemia-induced retinopathy. Mechoulam H, Pierce EA. Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4409-16. PubMed ID: 16303927 [Abstract] [Full Text] [Related]
11. Neuronal-driven angiogenesis: role of NGF in retinal neovascularization in an oxygen-induced retinopathy model. Liu X, Wang D, Liu Y, Luo Y, Ma W, Xiao W, Yu Q. Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3749-57. PubMed ID: 20207957 [Abstract] [Full Text] [Related]
12. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors. Tobe T, Okamoto N, Vinores MA, Derevjanik NL, Vinores SA, Zack DJ, Campochiaro PA. Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):180-8. PubMed ID: 9430560 [Abstract] [Full Text] [Related]
13. Localization of adenosine A2a receptor in retinal development and oxygen-induced retinopathy. Taomoto M, McLeod DS, Merges C, Lutty GA. Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):230-43. PubMed ID: 10634625 [Abstract] [Full Text] [Related]
16. Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. Kim I, Ryan AM, Rohan R, Amano S, Agular S, Miller JW, Adamis AP. Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2115-21. PubMed ID: 10440268 [Abstract] [Full Text] [Related]
17. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma. Hoshino M, Nakamura Y, Hamid QA. J Allergy Clin Immunol; 2001 Jun; 107(6):1034-8. PubMed ID: 11398081 [Abstract] [Full Text] [Related]
18. Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization. van Eeden PE, Tee LB, Lukehurst S, Lai CM, Rakoczy EP, Beazley LD, Dunlop SA. Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4638-45. PubMed ID: 17003462 [Abstract] [Full Text] [Related]
19. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity. Wilkinson-Berka JL, Jones D, Taylor G, Jaworski K, Kelly DJ, Ludbrook SB, Willette RN, Kumar S, Gilbert RE. Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398 [Abstract] [Full Text] [Related]
20. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation. Hu W, Jiang A, Liang J, Meng H, Chang B, Gao H, Qiao X. Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):407-15. PubMed ID: 18172119 [Abstract] [Full Text] [Related] Page: [Next] [New Search]